CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy Director bought 80,646 shares at $0.31 ($25,000)
- 4 Open-market buy COO, Secretary, Gen. Counsel bought 80,646 shares at $0.31 ($25,000)
- 4 Open-market buy CEO & President bought 161,291 shares at $0.31 ($50,000)
- 4 Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO & President acquired 32,895 shares (grant or award)
- 4 Grant or award Director acquired 24,500 shares (grant or award)
- 4 Grant or award COO, Secretary, Gen. Counsel acquired 4,902 shares (grant or award)
- 4 Grant or award CEO & President acquired 49,020 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award CEO & President acquired 21,552 shares (grant or award)
- 4 Grant or award CEO, President acquired 21,552 shares (grant or award)
Page 5 of 31 · 614 filings